Median effective dose of intranasal dexmedetomidine sedation for transthoracic echocardiography in pediatric patients with noncyanotic congenital heart disease: An up ‐and‐down sequential allocation trial

ConclusionsSingle‐dose of intranasal dexmedetomidine was an effective agent for patients under the age of 3 years requiring sedation for transthoracic echocardiography. The 50% effective dose of intranasal dexmedetomidine for transthoracic echocardiography sedation in children aged 13‐36 months was higher than in children <13 months.

Source: Pediatric Anesthesia - September 20, 2017 Category: Anesthesiology Authors: Qing Yu, Yang Liu, Mang Sun, Jing Zhang, Yan Zhao, Fengzhi Liu, Shangyingying Li, Shengfen Tu Tags: RESEARCH REPORT Source Type: research